Press release
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Sales Trends 2024
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market SizeThe global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market size is expected to reach US$ 3978.7 million by 2029, growing at a CAGR of 2.6% from 2023 to 2029.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-3C7231/Global_Methicillin_Resistant_Staphylococcus_Aureus_MRSA_Drugs_Market_Insights_and_Forecast_to_2028
The market is mainly driven by the significant applications of Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs in various end use industries. The expanding demands from the Hospital and Clinic, are propelling Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market. Bactrim, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Vancomycin segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market, driven by demand from China, the second largest economy with some signs of stabilising, the Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Key Companies:
• Takeda Pharmaceutical
• Merck
• AstraZeneca
• GlaxoSmithKline
• Pfizer
• Cubist Pharmaceuticals
• ViroPharma
• Forest Laboratories
• Theravance
By Type
• Bactrim
• Vancomycin
• Clindamycin
• Minocycline
By Application
• Hospital
• Clinic
View Full Report: https://reports.valuates.com/market-reports/QYRE-Auto-3C7231/global-methicillin-resistant-staphylococcus-aureus-mrsa-drugs
Email Id:
Please reach us at sales@valuates.com
Address:
Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066
Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Insights and Sales Trends 2024 here
News-ID: 3489368 • Views: …
More Releases from Valuates Reports
Software-Defined Everything (SDE) Market Size, Trends & Forecasts | Valuates Rep …
Software-Defined Everything (SDE) Market
Software-defined everything (SDE) is an umbrella term for a number of technologies that are helping redefine IT. Currently, this group of technologies encompasses software-defined networking (SDN), software-defined storage (SDS), and software-defined data centers (SDDC). Each approach aims to abstract the operating environment from physical infrastructure, while automating the processes that manage the infrastructure. By freeing businesses from proprietary hardware and simplifying the provisioning and management of IT…
AI Server Market Size, Trends & Forecasts | Valuates Reports
AI Server Market Size
The global AI Server market is projected to grow from US$ 31720 million in 2024 to US$ 78810 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.4% during the forecast period.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-24S15068/Global_AI_Server_Market_Research_Report_2023?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral
Major Trends
The global AI server market is driven by several key factors, including the rising adoption of artificial intelligence across various industries, advancements in AI technology, and the increasing need for…
Precision Air Conditioner Market Size, Trends & Forecasts | Valuates Reports
Precision Air Conditioner Market Size
The global Precision Air Conditioner revenue was US$ 4926.8 million in 2022 and is forecast to a readjusted size of US$ 7815.6 million by 2029 with a CAGR of 6.8% during the forecast period (2023-2029).
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-38A15722/Global_and_India_Precision_Air_Conditioner_Market_Report_Forecast_2023_2029?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral
The key precision air conditioning manufacturers are Vertiv, Stulz, Daikin etc. Top 3 companies occupied about 30% market share. China is the largest market, with a share about 35%,…
Non-Segregated Phase Bus Duct Market Set to Surge - Key Insights You Must Know
Non-Segregated Phase Bus Duct Market
Non-segregated phase bus is an assembly of bus conductors with associated connections, joints, and insulating supports confined within a metal enclosure without interphase barriers.
The global Non-Segregated Phase Bus Duct market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-21G10197/Global_Non_Segregated_Phase_Bus_Duct_Market_Insights_Forecast_to_2028?utm_source=openpr&utm_medium=referral&utm_campaign=openpr_referral
North American market for Non-Segregated Phase Bus Duct…
More Releases for Staphylococcus
Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025?
In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in…
Leading Growth Driver in the Methicillin-Resistant Staphylococcus Aureus (MRSA) …
What market dynamics are playing a key role in accelerating the growth of the methicillin-resistant staphylococcus aureus (mrsa) drugs market?
The growth of the methicillin-resistant Staphylococcus aureus drugs market is expected to be fuelled by the rise in Hospital Acquired Infections (HAIs). Patients acquire these infections while being treated at a healthcare center, usually 48 hours or more post admissions. The root causes behind HAIs include contaminated medical apparatus, lax hand…
Methicillin-Resistant Staphylococcus Aureus Testing Market Size, Share, Developm …
LP INFORMATION offers a latest published report on Methicillin-Resistant Staphylococcus Aureus Testing Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report.
According to this study, over the next five years the Methicillin-Resistant Staphylococcus Aureus Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million…
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
